Public Calendar: April 28 - May 4, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs
Event Date: 05/02/2019
Location: Washington, DC
Subject: Food and Drug Law Institute Annual Conference: FDA Priorities
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Government, media, industry, and other registered guests
Event Date: 05/02/2019
Location: Washington, DC
Subject: Reagan-Udall Foundation 2019 Annual Public Meeting: Agency Priorities
FDA Participant/Group: AMY ABERNETHY; JEFFREY SHUREN; SUSAN MAYNE; JANET WOODCOCK; PETER MARKS;
Non FDA Participant/Group: Government, industry, media, and other registered guests
Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner
Event Date: 04/29/2019
Location: Silver Spring, MD
Subject: Public Meeting: Patient Perspectives on the Impact of Rare Diseases: Bridging the Commonalities
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Patients, caregivers, health professionals, and industry related to rare diseases
Event Date: 04/30/2019
Location: Silver Spring, MD
Subject: MITRE Briefing on Federally Funded Research and Development Center (FFRDC): Health Pilot
FDA Participant/Group: PAUL HOWARD; JOSEPH FRANKLIN; KELLY NORSWORTHY; SEAN KHOZIN; JESSICA BERRELLEZ;
Non FDA Participant/Group: Monica Bertagnolli (American Society of Clinical Oncology); Keri Reardon, Steven Piantadosi (The Alliance for Clinical Trials in Oncology); Brian Anderson, Erin Williams, Jay Schnitzer (The MITRE Corporation); Lawrence Schwartz (New York Presbyterian Hospital);
Event Date: 05/02/2019
Location: Washington, DC
Subject: Medical Device Manufacturers Association 2019 Annual Meeting: Driving the Future of Healthcare
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Government, industry, academia, and the health care services field
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Lowell J. Schiller, Principal Associate Commissioner for Polcy
Event Date: 05/02/2019
Location: Silver Spring, MD
Subject: Dietary Supplements Quality Collaborative Meeting
FDA Participant/Group: CAITLIN BOON; ALEXANDRA HEARD; CARA WELCH; STEVEN TAVE; TRACEY SANDERS;
Non FDA Participant/Group: Elise Ackley (The Pew Charitable Trusts); Jay Sirois (Healthcare Products Association); Steve Mister (Council for Responsible Nutrition); Carrie Harney (Dietary Supplements Quality Collaborative); Elizabeth Miller (The United States Pharmacopeial Convention);
Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 04/30/2019
Location: Washington, DC
Subject: Food Marketing Institute: FDA Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the Food Marketing Institute, Government Relations and Public Affairs Committee
Event Date: 05/02/2019
Location: Washington, DC
Subject: American Frozen Food Institute Board Meeting
FDA Participant/Group: SUSAN KELLY;
Non FDA Participant/Group: N/A
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Keagan Lenihan, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date: 05/02/2019
Location: Washington, DC
Subject: Food and Drug Law Institute Annual Conference: Goals and Priorities for CDER
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: N/A
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 04/28/2019
Location: Washington, DC
Subject: American Society of Gene and Cell Therapy 22nd Annual Meeting: FDA's Approach to Facilitating the Development of Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Event Date: 05/01/2019
Location: Washington, DC
Subject: American Society of Gene and Cell Therapy 22nd Annual Meeting: FDA's Programs to Promote Patient Access to Investigational Therapies
FDA Participant/Group: WILSON BRYAN;
Non FDA Participant/Group: N/A
Event Date: 05/02/2019
Location: Washington, DC
Subject: Food and Drug Law Institute Annual Conference: Exploring Advanced Topics in Food and Drug Law: Center for Biologics Evaluation and Research Update
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 04/30/2019
Location: Washington, DC
Subject: 2019 KidneyX Summit: FDA Role
FDA Participant/Group: MURRAY SHELDON;
Non FDA Participant/Group: N/A
Event Date: 05/02/2019
Location: Washington, DC
Subject: Food and Drug Law Institute Annual Conference: Center Director Session
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Event Date: 05/03/2019
Location: Silver Spring, MD
Subject: Digital Health and Precertification Pilot
FDA Participant/Group: WILLIAM MAISEL; BRADLEY CUNNINGHAM; JESSICA PAULSEN; BAKUL PATEL;
Non FDA Participant/Group: Eric Friedman, Gloria Lee (Fitbit, Inc.);
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
Event Date: 04/29/2019
Location: Little Rock, AR
Subject: The Delta Directions Consortium
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited guests
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event